HCV Infection of Hematopoietic and Immune Cell Subsets



Although hepatitis C virus (HCV) is conventionally known to infect hepatocytes, a significant body of molecular and clinical evidence implies that HCV also invades and persists in cells of the immune system. The functional and pathological consequences of HCV lymphotropism have become increasingly recognized. Studies on HCV compartmentalization in patients with symptomatic or clinically silent (occult) HCV infections demonstrated viral replication in different immune cell subsets, while experiments with primary immune cells and stable cell lines satisfactorily documented the cells’ competence to support HCV propagation in vitro. In this chapter, we present an overview of our current understanding of lymphoid cell involvement in HCV infection in patients with chronic hepatitis C and in those with low-level, essentially asymptomatic HCV infection. We also discuss the methods and pitfalls of HCV detection in immune cells and review the data on in vitro infection of lymphoid cells with wild-type HCV isolates.


Sustained Virological Response Internal Ribosomal Entry Site Immune Cell Subset Hepatoma Huh7 Cell Signaling Lymphocyte Activation Molecule 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Blackard JT, Kemmer N, Sherman KE (2006) Extrahepatic replication of HCV: insights into clinical manifestations and biological consequences. Hepatology 44:15–22PubMedCrossRefGoogle Scholar
  2. 2.
    Zignego AL, Giannini C, Monti M, Gragnani L (2007) Hepatitis C virus lymphotropism: lessons from a decade of studies. Dig Liver Dis 39(Suppl 1):S38–S45PubMedCrossRefGoogle Scholar
  3. 3.
    Oldstone MB (1996) Virus-lymphoid cell interactions. Proc Natl Acad Sci USA 93:12756–12758PubMedCrossRefGoogle Scholar
  4. 4.
    Chang TT, Young KC, Yang YJ et al (1996) Hepatitis C virus RNA in peripheral blood mononuclear cells: comparing acute and chronic hepatitis C virus infection. Hepatology 23:977–981PubMedCrossRefGoogle Scholar
  5. 5.
    Gong GZ, Lai LY, Jiang YF et al (2003) HCV replication in PBMC and its influence on interferon therapy. World J Gastroenterol 9:291–294PubMedGoogle Scholar
  6. 6.
    Lerat H, Rumin S, Habersetzer F et al (1998) In vivo tropism of hepatitis C virus genomic sequences in hematopoietic cells: influence of viral load, viral genotype, and cell phenotype. Blood 91:3841–3849PubMedGoogle Scholar
  7. 7.
    Morsica G, Tambussi G, Sitia G et al (1999) Replication of hepatitis C virus in B lymphocytes (CD19+). Blood 94:1138–1139PubMedGoogle Scholar
  8. 8.
    Pal S, Sullivan DG, Kim S et al (2006) Productive replication of hepatitis C virus in perihepatic lymph nodes in vivo: ­implications of HCV lymphotropism. Gastroenterology 130:1107–1116PubMedCrossRefGoogle Scholar
  9. 9.
    Inokuchi M, Ito T, Uchikoshi M et al (2009) Infection of B cells with hepatitis C virus for the development of lymphoproliferative disorders in patients with chronic hepatitis C. J Med Virol 81:619–627PubMedCrossRefGoogle Scholar
  10. 10.
    Pham TN, King D, MacParland SA et al (2008) Hepatitis C virus replicates in the same immune cell subsets in chronic hepatitis C and occult infection. Gastroenterology 134:812–822PubMedCrossRefGoogle Scholar
  11. 11.
    Roque-Afonso AM, Ducoulombier D, Di Liberto G et al (2005) Compartmentalization of hepatitis C virus genotypes between plasma and peripheral blood mononuclear cells. J Virol 79:6349–6357PubMedCrossRefGoogle Scholar
  12. 12.
    Zignego AL, Macchia D, Monti M et al (1992) Infection of peripheral mononuclear blood cells by hepatitis C virus. J Hepatol 15:382–386PubMedCrossRefGoogle Scholar
  13. 13.
    Di Liberto G, Roque-Afonso AM, Kara R et al (2006) Clinical and therapeutic implications of hepatitis C virus compartmentalization. Gastroenterology 131:76–84PubMedCrossRefGoogle Scholar
  14. 14.
    Ducoulombier D, Roque-Afonso AM, Di Liberto G et al (2004) Frequent compartmentalization of hepatitis C virus variants in circulating B cells and monocytes. Hepatology 39:817–825PubMedCrossRefGoogle Scholar
  15. 15.
    Navas S, Martin J, Quiroga JA, Castillo I et al (1998) Genetic diversity and tissue compartmentalization of the hepatitis C virus genome in blood mononuclear cells, liver, and serum from chronic hepatitis C patients. J Virol 72:1640–1646PubMedGoogle Scholar
  16. 16.
    Vera-Otarola J, Barria MI, Leon U et al (2009) Hepatitis C virus quasispecies in plasma and peripheral blood mononuclear cells of treatment naive chronically infected patients. J Viral Hepat 16:633–643PubMedCrossRefGoogle Scholar
  17. 17.
    Forton DM, Karayiannis P, Mahmud N et al (2004) Identification of unique hepatitis C virus quasispecies in the central nervous system and comparative analysis of internal translational efficiency of brain, liver, and serum variants. J Virol 78:5170–5183PubMedCrossRefGoogle Scholar
  18. 18.
    Laporte J, Bain C, Maurel P et al (2003) Differential distribution and internal translation efficiency of hepatitis C virus quasispecies present in dendritic and liver cells. Blood 101:52–57PubMedCrossRefGoogle Scholar
  19. 19.
    Durand T, Di Liberto G, Colman H et al (2010) Occult infection of peripheral B cells by hepatitis C variants which have low translational efficiency in cultured hepatocytes. Gut 59:934–942PubMedCrossRefGoogle Scholar
  20. 20.
    Gisbert JP, Garcia-Buey L, Pajares JM, Moreno-Otero R (2003) Prevalence of hepatitis C virus infection in B-cell non-Hodgkin’s lymphoma: systematic review and meta-analysis. Gastroenterology 125:1723–1732PubMedCrossRefGoogle Scholar
  21. 21.
    Matsuo K, Kusano A, Sugumar A et al (2004) Effect of hepatitis C virus infection on the risk of non-Hodgkin’s lymphoma: a meta-analysis of epidemiological studies. Cancer Sci 95:745–752PubMedCrossRefGoogle Scholar
  22. 22.
    Agnello V, De Rosa FG (2004) Extrahepatic disease manifestations of HCV infection: some current issues. J Hepatol 40:341–352PubMedCrossRefGoogle Scholar
  23. 23.
    Ferri C, Monti M, La Civita L et al (1993) Infection of peripheral blood mononuclear cells by hepatitis C virus in mixed cryoglobulinemia. Blood 82:3701–3704PubMedGoogle Scholar
  24. 24.
    Mizorogi F, Hiramoto J, Nozato A et al (2000) Hepatitis C virus infection in patients with B-cell non-Hodgkin’s lymphoma. Intern Med 39:112–117PubMedCrossRefGoogle Scholar
  25. 25.
    Martyak LA, Yeganeh M, Saab S (2009) Hepatitis C and lymphoproliferative disorders: from mixed cryoglobu­linemia to non-Hodgkin’s lymphoma. Clin Gastroenterol Hepatol 7:900–905PubMedCrossRefGoogle Scholar
  26. 26.
    Bagaglio S, Cinque P, Racca S et al (2005) Hepatitis C virus populations in the plasma, peripheral blood mononuclear cells and cerebrospinal fluid of HIV/hepatitis C virus-co-infected patients. AIDS 19(Suppl 3):S151–S165PubMedCrossRefGoogle Scholar
  27. 27.
    Radkowski M, Wilkinson J, Nowicki M et al (2002) Search for hepatitis C virus negative-strand RNA sequences and analysis of viral sequences in the central nervous system: evidence of replication. J Virol 76:600–608PubMedCrossRefGoogle Scholar
  28. 28.
    Sansonno D, Lotesoriere C, Cornacchiulo V et al (1998) Hepatitis C virus infection involves CD34(+) hematopoietic progenitor cells in hepatitis C virus chronic carriers. Blood 92:3328–3337PubMedGoogle Scholar
  29. 29.
    Bronowicki JP, Loriot MA, Thiers V et al (1998) Hepatitis C virus persistence in human hematopoietic cells injected into SCID mice. Hepatology 28:211–218PubMedCrossRefGoogle Scholar
  30. 30.
    Pham TN, MacParland SA, Mulrooney PM et al (2004) Hepatitis C virus persistence after spontaneous or treatment-induced resolution of hepatitis C. J Virol 78:5867–5874PubMedCrossRefGoogle Scholar
  31. 31.
    Radkowski M, Gallegos-Orozco JF, Jablonska J et al (2005) Persistence of hepatitis C virus in patients successfully treated for chronic hepatitis C. Hepatology 41:106–114PubMedCrossRefGoogle Scholar
  32. 32.
    Ciancio A, Smedile A, Giordanino C (2006) Long-term follow-up of previous hepatitis C virus positive nonresponders to interferon monotherapy successfully retreated with combination therapy: are they really cured? Am J Gastroenterol 101:1811–1816PubMedCrossRefGoogle Scholar
  33. 33.
    Gallegos-Orozco JF, Rakela J, Rosati MJ et al (2008) Persistence of hepatitis C virus in peripheral blood mononuclear cells of sustained viral responders to pegylated interferon and ribavirin therapy. Dig Dis Sci 53:2564–2568PubMedCrossRefGoogle Scholar
  34. 34.
    Michalak TI, Pham TN (2009) Anti-HCV core antibody: a potential new marker of occult and otherwise serologically silent HCV infection. J Hepatol 50:244–246PubMedCrossRefGoogle Scholar
  35. 35.
    Bernardin F, Tobler L, Walsh I et al (2008) Clearance of ­hepatitis C virus RNA from the peripheral blood ­mononuclear cells of blood donors who spontaneously or ­therapeutically control their plasma viremia. Hepatology 47:1446–1452PubMedCrossRefGoogle Scholar
  36. 36.
    George SL, Bacon BR, Brunt EM et al (2009) Clinical, virologic, histologic, and biochemical outcomes after successful HCV therapy: a 5-year follow-up of 150 patients. Hepatology 49:729–738PubMedCrossRefGoogle Scholar
  37. 37.
    Marcellin P, Boyer N, Gervais A et al (1997) Long-term ­histologic improvement and loss of detectable intrahepatic HCV RNA in patients with chronic hepatitis C and sustained response to interferon-alpha therapy. Ann Intern Med 127:875–881PubMedCrossRefGoogle Scholar
  38. 38.
    Maylin S, Martinot-Peignoux M, Ripault MP et al (2009) Sustained virological response is associated with clearance of hepatitis C virus RNA and a decrease in hepatitis C virus antibody. Liver Int 29:511–517PubMedCrossRefGoogle Scholar
  39. 39.
    Pham TN, Coffin CS, Michalak TI (2010) Occult hepatitis C virus infection: what does it mean? Liver Int 30:502–511PubMedCrossRefGoogle Scholar
  40. 40.
    Casanovas-Taltavull T, Ercilla MG et al (2004) Long-term immune response after liver transplantation in patients with spontaneous or post-treatment HCV-RNA clearance. Liver Transpl 10:584–594PubMedCrossRefGoogle Scholar
  41. 41.
    Pillai V, Lee WM, Thiele DL, Karandikar NJ (2007) Clinical responders to antiviral therapy of chronic HCV infection show elevated antiviral CD4+ and CD8+ T-cell responses. J Viral Hepat 14:318–329PubMedCrossRefGoogle Scholar
  42. 42.
    Quiroga JA, Llorente S, Castillo I et al (2006) Virus-specific T-cell responses associated with hepatitis C virus (HCV) persistence in the liver after apparent recovery from HCV infection. J Med Virol 78:1190–1197PubMedCrossRefGoogle Scholar
  43. 43.
    Pham TNQ, Mercer SE, Michalak TI (2009) Chronic hepatitis C and persistent occult hepatitis C virus infection are characterized by distinct immune cell cytokine expression profiles. J Viral Hepat 16:547–556PubMedCrossRefGoogle Scholar
  44. 44.
    MacParland SA, Pham TN, Guy CS, Michalak TI (2009) Hepatitis C virus persisting after clinically apparent sustained virological response to antiviral therapy retains infectivity in vitro. Hepatology 49:1431–1441PubMedCrossRefGoogle Scholar
  45. 45.
    Castillo I, Pardo M, Bartolome J et al (2004) Occult hepatitis C virus infection in patients in whom the etiology of persistently abnormal results of liver-function tests is unknown. J Infect Dis 189:7–14PubMedCrossRefGoogle Scholar
  46. 46.
    Schmidt WN, Wu P, Cederna J et al (1997) Surreptitious hepatitis C virus (HCV) infection detected in the majority of patients with cryptogenic chronic hepatitis and negative HCV antibody tests. J Infect Dis 176:27–33PubMedCrossRefGoogle Scholar
  47. 47.
    Stapleton JT, Schmidt WN, Katz L (2004) Seronegative hepatitis C virus infection, not just RNA detection. J Infect Dis 190:651–652PubMedCrossRefGoogle Scholar
  48. 48.
    Quiroga JA, Llorente S, Castillo I et al (2006) Cellular immune responses associated with occult hepatitis C virus infection of the liver. J Virol 80:10972–10979PubMedCrossRefGoogle Scholar
  49. 49.
    Halfon P, Bourliere M, Ouzan D et al (2008) Occult hepatitis C virus infection revisited with ultrasensitive real-time PCR assay. J Clin Microbiol 46:2106–2108PubMedCrossRefGoogle Scholar
  50. 50.
    Pham TN, MacParland SA, Coffin CS et al (2005) Mitogen-induced upregulation of hepatitis C virus expression in human lymphoid cells. J Gen Virol 86:657–666PubMedCrossRefGoogle Scholar
  51. 51.
    Kondo Y, Sung VM, Machida K et al (2007) Hepatitis C virus infects T cells and affects interferon-gamma signaling in T cell lines. Virology 361:161–173PubMedCrossRefGoogle Scholar
  52. 52.
    Kondo Y, Machida K, Liu HM et al (2009) Hepatitis C virus infection of T cells inhibits proliferation and enhances Fas-mediated apoptosis by down-regulating the expression of CD44 splicing variant 6. J Infect Dis 199:726–736PubMedCrossRefGoogle Scholar
  53. 53.
    Cribier B, Schmitt C, Bingen A et al (1995) In vitro infection of peripheral blood mononuclear cells by hepatitis C virus. J Gen Virol 76:2485–2491PubMedCrossRefGoogle Scholar
  54. 54.
    MacParland SA, Pham TN, Gujar SA, Michalak TI (2006) De novo infection and propagation of wild-type Hepatitis C virus in human T lymphocytes in vitro. J Gen Virol 87:3577–3586PubMedCrossRefGoogle Scholar
  55. 55.
    Laskus T, Radkowski M, Jablonska J et al (2004) Human immunodeficiency virus facilitates infection/replication of hepatitis C virus in native human macrophages. Blood 103:3854–3859PubMedCrossRefGoogle Scholar
  56. 56.
    Radkowski M, Bednarska A, Horban A et al (2004) Infection of primary human macrophages with hepatitis C virus in vitro: induction of tumour necrosis factor-alpha and interleukin 8. J Gen Virol 85:47–59PubMedCrossRefGoogle Scholar
  57. 57.
    Marukian S, Jones CT, Andrus L et al (2008) Cell culture-produced hepatitis C virus does not infect peripheral blood mononuclear cells. Hepatology 48:1843–1850PubMedCrossRefGoogle Scholar
  58. 58.
    Murakami K, Kimura T, Osaki M et al (2008) Virological characterization of the hepatitis C virus JFH-1 strain in lymphocytic cell lines. J Gen Virol 89:1587–1592PubMedCrossRefGoogle Scholar
  59. 59.
    Tatsuo H, Ono N, Tanaka K, Yanagi Y (2000) SLAM (CDw150) is a cellular receptor for measles virus. Nature 406:893–897PubMedCrossRefGoogle Scholar
  60. 60.
    Watanabe A, Yoneda M, Ikeda F et al (2010) CD147/EMMPRIN acts as a functional entry receptor for measles virus on epithelial cells. J Virol 84:4183–4193PubMedCrossRefGoogle Scholar
  61. 61.
    Sarhan MA, Michalak TI (2009) CD5-Mediated susceptibility of human T lymphocytes to wild-type hepatitis C virus. Hepatology 50:350AGoogle Scholar

Copyright information

© Springer-Verlag Italia 2012

Authors and Affiliations

  1. 1.Molecular Virology and Hepatology Research Group, Faculty of Medicine, Health Sciences CenterMemorial UniversitySt. John’sCanada

Personalised recommendations